FDA drafts AI-enabled medical device lifecycle plan guidance

The Food and Drug Administration announced the availability of draft guidance that provides recommendations on lifecycle controls in submissions to market machine learning-enabled device software functions.
WHY IT MATTERS
In the “Marketing Submission Recommendations for a Predetermined Change…

From: www.healthcareitnews.com – Read more